Best Capacity Building Grants for Nonprofits in New Mexico

The Macy Faculty Scholars Program, funded by the Josiah Macy Jr. Foundation, supports early-career educators in medicine and nursing, promoting their development as future leaders. Scholars receive substantial financial support, mentorship, and access to educational resources, including funding for professional development activities and participation in a Harvard Macy Institute course. This initiative aims to enhance the educational landscape by nurturing diverse talent in the healthcare education field.

The AINA Grant-in-Aid program, established by the Arctic Institute of North America, provides funding of $1000 to support young investigators, particularly graduate students, in their research related to Arctic issues. Eligible applicants must be affiliated with a U.S. or Canadian academic institution. The funding can cover travel, supplies, and equipment but not salaries. The program emphasizes the relevance and quality of research proposals that engage the Arctic community.

The Dermatology Foundation offers Career Development Awards to support the academic growth of emerging investigators in various dermatologic fields. With an annual stipend of $55,000, these awards foster research addressing significant health issues, including public health, diversity, and women's health. Eligible applicants must demonstrate strong institutional support and meet specific educational requirements. The awards can be renewed for up to three years, contingent on the recipient's progress and commitment to advancing dermatological science.

The Medical Student Research Supplement Award by the Dermatology Foundation supports medical students' research in dermatology, encouraging diversity and inclusion. This award offers $5,000 for direct research expenses, fostering the involvement of full-time students from underrepresented backgrounds. Eligible applicants must be current or former DF career development awardees and must recruit medical students pursuing MD or DO degrees who meet specific academic criteria. The award enhances research participation and strengthens the academic workforce in dermatology.

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Acute Myeloid Leukemia (AML) Fund

Help with healthcare costs for acute myeloid leukemia

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses. 

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Chronic Lymphocytic Leukemia (CLL) Fund

Help with healthcare costs for chronic lymphocytic leukemia

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses. 

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See Approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Hemophilia Fund

Help with healthcare costs for hemophilia

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Hemophilia Health Equity Fund

Help with healthcare costs for hemophilia (health equity fund)

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

Health Equity Funds offer help to eligible patients living in areas identified as having increased social and financial needs, as well as higher rates of chronic conditions. Eligibility is determined in part by home address zip code. 

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Mucopolysaccharidosis Type III (MPS III) Fund

Help with healthcare costs for mucopolysaccharidosis type III

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses. 

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Mucopolysaccharidosis Type VII (MPS VII) Fund

Help with healthcare costs for mucopolysaccharidosis type VII

This TotalAssist Health Equity Fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Mucopolysaccharidosis Type VII (MPS VII) Health Equity Fund

Help with healthcare costs for mucopolysaccharidosis type VII (health equity)

This TotalAssist Health Equity Fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

Health Equity Funds offer help to eligible patients living in areas identified as having increased social and financial needs, as well as higher rates of chronic conditions. Eligibility is determined in part by home address zip code.

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

The Cancer Research Education Grants Program (R25) aims to enhance research education in areas crucial to the NIH mission. This program supports innovative courses that develop skills in cancer research, covering topics such as prevention, diagnosis, and treatment. Grant applications are encouraged to be creative and state-of-the-art, addressing the needs of patients and their families. Key deadlines for applications span from January 2024 to September 2026, ensuring ongoing support for educational initiatives.

The Sanofi-Regeneron Diversity, Equity and Inclusion Mid-Career Award, funded by the Dermatology Foundation, supports exceptional researchers committed to addressing dermatological issues affecting underrepresented groups. Offering $100,000 annually for up to three years, this award emphasizes projects that enhance understanding and improve health equity in dermatology. Eligibility includes a strong research commitment, relevant training, and a faculty appointment within 12 years of becoming an Assistant Professor. It encourages minority applicants to foster diversity in medical research.

The Cindy Colglazier Scholarship, managed by the Brown County Community Foundation, aims to support students pursuing education in healthcare fields at accredited institutions. This scholarship is available to residents of Bartholomew, Brown, and Monroe Counties, including high school graduates, current college students, and G.E.D. graduates. The Foundation has a long-standing commitment to education and provides essential funding to help students achieve their academic goals.

The Dorothy Stewart Memorial Scholarship, managed by the Brown County Community Foundation, aims to foster interest in public and environmental affairs. It provides financial support to graduates of Brown County High School or G.E.D. recipients who demonstrate exceptional citizenship and community involvement. Eligible candidates must pursue a degree in relevant fields, ensuring that the scholarship contributes to the development of future leaders in these critical areas.

The Harry D. Poling Scholarship, managed by the Brown County Community Foundation, supports current and former 4-H members pursuing higher education or vocational training. Established to assist students from Brown County, this scholarship prioritizes those seeking CDL or vocational training, emphasizing financial need. Since 1993, the Foundation has focused on educational initiatives, providing numerous scholarships to local graduates and working closely with The Lilly Endowment Inc. for enhanced educational opportunities.

The Faye Lynn Deckard Memorial Scholarship Fund, managed by the Brown County Community Foundation, aims to provide scholarships for students accepted into accredited two- or four-year institutions. This fund supports residents of Brown County pursuing degrees in early childhood education, ensuring that financial barriers do not hinder their educational aspirations. Since its inception, the foundation has been dedicated to enhancing educational opportunities for local students, reinforcing its commitment to community development and academic achievement.

The RNomics Technology Enhancement Centers, supported by the NIH Common Fund, aim to enhance tools for comprehensive RNA analysis, facilitating insights into health and disease. This initiative focuses on developing technologies for RNA sequencing, modification mapping, and functional testing. By fostering collaborations and strengthening existing resources, RTECs will advance the study of RNA molecules, ensuring broad community access to improved experimental and computational methods.

The RNomics Outreach and Coordination (ROC) Center, established by the NIH Common Fund, aims to enhance understanding of RNA molecules through integrated analysis. This center will serve as a hub for data management and community engagement, developing a central data portal, supporting data standards, and coordinating consortium-wide analyses. By fostering collaborations and providing training, the ROC Center seeks to ensure the long-term availability of essential RNomics resources, ultimately advancing health and disease research.

The RNomics Molecular Standards initiative, supported by the NIH Common Fund, aims to enhance research on RNA molecules by developing standardized references. This program will facilitate the creation, testing, and distribution of RNA molecular reference standards, which are crucial for ensuring consistency and reliability in RNA research. By providing guidance on best practices and planning for long-term availability, RNomics will help advance technologies that analyze RNA sequences and functions, ultimately improving health and disease understanding.

The NIH Common Fund is launching the RNomics program to advance RNA research through innovative technologies. This initiative focuses on developing tools for comprehensive analysis of RNA molecules, addressing current methodological limitations. Key priorities include sequencing RNA, detecting modifications, and studying RNA function across various biological contexts. The program encourages high-risk, early-stage projects that demonstrate potential for significant impact. Successful Phase 1 projects may transition to Phase 2, aimed at delivering validated resources for the research community.

The HEAL Initiative aims to develop non-addictive therapeutics for pain management through small molecules and biologics. This funding opportunity supports preclinical optimization, facilitating the transition of promising candidates to clinical trials. Important proposal deadlines span from January 2024 to January 2027, with optional Letters of Intent encouraged 30 days prior. The program emphasizes collaboration with NIH staff to ensure thorough project planning and monitoring, aiming to revolutionize pain treatment while ensuring safety and efficacy.

The National Cancer Institute invites applications for the validation of biomarkers and assays for cancer detection and treatment. This funding opportunity supports both analytical and clinical validation of assays, emphasizing the importance of human samples. The program encourages multi-disciplinary collaboration and aims to enhance the performance and reproducibility of cancer assays across clinical laboratories. Applications are due by 5:00 PM local time during the designated deadlines each year.

The ASRM/PSF Combined Pilot Research Grant, funded by the Plastic Surgery Foundation, aims to support innovative research in reconstructive microsurgery. By providing up to $10,000 for 1-year pilot projects, this grant encourages the development of surgeon scientists and promotes the advancement of scientific knowledge and clinical practices in the field. The initiative fosters collaboration among key organizations dedicated to enhancing research funding for impactful studies.

The Combined Pilot Research Grants from the Plastic Surgery Foundation and the American Society of Maxillofacial Surgeons aim to promote innovative research in maxillofacial surgery. With funding of up to $15,000 for one-year pilot projects, this initiative supports the preliminary phases of research, fostering the development of surgeon scientists and enhancing scientific knowledge in the field. Eligible applicants include MDs, DOs, or PhDs holding full-time positions in U.S. or Canadian institutions.

The Domestic Violence Prevention (DVP) grant from the IHS aims to enhance the capacity of Tribes and Urban Indian Organizations to combat domestic and sexual violence. This initiative promotes culturally appropriate, trauma-informed services, focusing on victim advocacy and collaboration across sectors. It addresses critical issues like human trafficking and child maltreatment, ensuring long-term sustainability through evidence-based practices and data sharing, ultimately improving community health and safety for AI/AN populations.

The Combined Pilot Research Grants by the AAPPS and PSF aim to promote innovative research in pediatric plastic surgery and hand surgery. With funding up to $15,000 for one-year pilot projects, these grants support the development of surgeon scientists and encourage applications that will enhance the scientific understanding and improve care for children with deformities requiring reconstructive surgery. This initiative fosters collaboration among various subspecialty organizations dedicated to advancing surgical research.